Home/Filings/4/0001725160-21-000029
4//SEC Filing

Kariuki Enoch 4

Accession 0001725160-21-000029

CIK 0001725160other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 9:41 AM ET

Size

5.5 KB

Accession

0001725160-21-000029

Insider Transaction Report

Form 4
Period: 2021-02-09
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-09+42,00042,000 total
    Exercise: $39.47Exp: 2031-02-08Common Stock (42,000 underlying)
Footnotes (1)
  • [F1]The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant.

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1
  • filerCIK 0001843119

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 9:41 AM ET
Size
5.5 KB